Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Details : Levonorgestrel is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Contraceptives, Oral.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
December 27, 2013
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cervical Ripening.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 02, 2011
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
